Literature DB >> 8893712

Hyperemia following traumatic brain injury: relationship to intracranial hypertension and outcome.

D F Kelly1, R K Kordestani, N A Martin, T Nguyen, D A Hovda, M Bergsneider, D L McArthur, D P Becker.   

Abstract

The role of posttraumatic hyperemia in the development of raised intracranial pressure (ICP) has important pathophysiological and therapeutic implications. To determine the relationship between hyperemia (cerebral blood flow (CBF) > 55 ml/100 g/minute), intracranial hypertension (ICP > 20 mm Hg), and neurological outcome, 193 simultaneous measurements of ICP and CBF (xenon-133 method) were obtained in 59 patients with moderate and severe head injury. Hyperemia was associated with an increased incidence of simultaneous intracranial hypertension compared to nonhyperemic CBF measurements (32.2% vs. 21.6%, respectively; p < 0.059). However, in 78% of blood flow studies in which ICP was greater than 20 mm Hg, CBF was less than or equal to 55 ml/100 g/minute. At least one episode of hyperemia was documented in 34% of patients, all of whom had a Glasgow Coma Scale (GCS) score of 9 or below. In 12 individuals with hyperemia without simultaneous intracranial hypertension, ICP was greater than 20 mm Hg for an average of 11 +/- 16 hours and favorable outcomes were seen in 75% of patients. In contrast, in eight individuals with hyperemia and at least one episode of hyperemia-associated intracranial hypertension, ICP was greater than 20 mm Hg for an average of 148 +/- 84 hours (p < 0.001), and a favorable outcome was seen in only one patient (p < 0.001). Compared to the remainder of the cohort, patients with hyperemia-associated intracranial hypertension were distinctive in being the youngest, exhibiting the lowest GCS scores (all < or = 6), and having the highest incidence of effaced basilar cisterns and intractable intracranial hypertension. In the majority of individuals with hyperemia-associated intracranial hypertension, their clinical profile suggests the occurrence of a severe initial insult with resultant gross impairment of metabolic vasoreactivity and pressure autoregulation. In a minority of these patients, however, high CBF may be coupled to a hypermetabolic state, given their responsiveness to metabolic suppressive therapy. In patients with hyperemia but without intracranial hypertension, elevated CBF is also likely to be a manifestation of appropriate coupling to increased metabolic demand consistent with a generally favorable outcome. This study supports the concept that there are multiple etiologies of both elevated blood flow and intracranial hypertension after head injury.

Entities:  

Mesh:

Year:  1996        PMID: 8893712     DOI: 10.3171/jns.1996.85.5.0762

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  18 in total

Review 1.  The Utility of Cerebral Blood Flow Assessment in TBI.

Authors:  Omar S Akbik; Andrew P Carlson; Mark Krasberg; Howard Yonas
Journal:  Curr Neurol Neurosci Rep       Date:  2016-08       Impact factor: 5.081

2.  Cerebral blood volume alterations in the perilesional areas in the rat brain after traumatic brain injury--comparison with behavioral outcome.

Authors:  Riikka Immonen; Taneli Heikkinen; Leena Tähtivaara; Antti Nurmi; Taina-Kaisa Stenius; Jukka Puoliväli; Tinka Tuinstra; Amie L Phinney; Bernard Van Vliet; Juha Yrjänheikki; Olli Gröhn
Journal:  J Cereb Blood Flow Metab       Date:  2010-02-10       Impact factor: 6.200

3.  Xenon-CT and transcranial Doppler in poor-grade or complicated aneurysmatic subarachnoid hemorrhage patients undergoing aggressive management of intracranial hypertension.

Authors:  Arturo Chieregato; Giuseppe Sabia; Alessandra Tanfani; Christian Compagnone; Fernanda Tagliaferri; Luigi Targa
Journal:  Intensive Care Med       Date:  2006-06-17       Impact factor: 17.440

4.  My paper 20 years later: cerebral venous oxygen saturation studied with bilateral samples in the internal jugular veins.

Authors:  N Stocchetti; S Magnoni; E R Zanier
Journal:  Intensive Care Med       Date:  2015-01-23       Impact factor: 17.440

5.  Autoregulation of Cerebral Blood Flow During 3-h Continuous Cardiopulmonary Resuscitation at 27°C.

Authors:  Sergei Valkov; Jan Harald Nilsen; Rizwan Mohyuddin; Torstein Schanche; Timofei Kondratiev; Gary C Sieck; Torkjel Tveita
Journal:  Front Physiol       Date:  2022-06-09       Impact factor: 4.755

6.  Should the neurointensive care management of traumatic brain injury patients be individualized according to autoregulation status and injury subtype?

Authors:  Ulf Johnson; Anders Lewén; Elisabeth Ronne-Engström; Tim Howells; Per Enblad
Journal:  Neurocrit Care       Date:  2014-10       Impact factor: 3.210

7.  Cerebral hemodynamic changes of mild traumatic brain injury at the acute stage.

Authors:  Hardik Doshi; Natalie Wiseman; Jun Liu; Wentao Wang; Robert D Welch; Brian J O'Neil; Conor Zuk; Xiao Wang; Valerie Mika; Jerzy P Szaflarski; E Mark Haacke; Zhifeng Kou
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

8.  Posttraumatic refractory intracranial hypertension and brain herniation syndrome: cerebral hemodynamic assessment before decompressive craniectomy.

Authors:  Edson Bor-Seng-Shu; Wellingson Silva Paiva; Eberval G Figueiredo; Yasunori Fujimoto; Almir Ferreira de Andrade; Erich Talamoni Fonoff; Manoel Jacobsen Teixeira
Journal:  Biomed Res Int       Date:  2013-11-27       Impact factor: 3.411

Review 9.  Capillary transit time heterogeneity and flow-metabolism coupling after traumatic brain injury.

Authors:  Leif Østergaard; Thorbjørn S Engedal; Rasmus Aamand; Ronni Mikkelsen; Nina K Iversen; Maryam Anzabi; Erhard T Næss-Schmidt; Kim R Drasbek; Vibeke Bay; Jakob U Blicher; Anna Tietze; Irene K Mikkelsen; Brian Hansen; Sune N Jespersen; Niels Juul; Jens C H Sørensen; Mads Rasmussen
Journal:  J Cereb Blood Flow Metab       Date:  2014-07-23       Impact factor: 6.200

Review 10.  Traumatic brain injury: pathophysiology for neurocritical care.

Authors:  Kosaku Kinoshita
Journal:  J Intensive Care       Date:  2016-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.